ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: PUB038

IV Iron in Iron-Deficient, Nonanaemic Patients with Nondialysis-Dependent (ND)-CKD: A Systematic Review

Session Information

Category: Anemia and Iron Metabolism

  • 200 Anemia and Iron Metabolism

Authors

  • Spencer, Sebastian, University of Hull, Hull, England, United Kingdom
  • Skidmore, Megan, Hull York Medical School, Hull, England, United Kingdom
  • Bhandari, Sunil, Hull University Teaching Hospitals NHS Trust, Hull, England, United Kingdom
Background

Iron deficiency is common in ND-CKD and may cause symptoms such as fatigue and restless legs, even in the absence of anaemia. While IV iron is widely used in haemodialysis, its safety and efficacy in iron-deficient but non-anaemic ND-CKD remain unclear. Guidelines lack specific recommendations for this group, except in patients with heart failure. Trials in CKD and heart failure suggest potential benefit, but applicability to this population is uncertain. This systematic review aims to assess the safety, efficacy, and patient outcomes of IV iron in ND-CKD with confirmed ID and Hb 110–150 g/L.

Methods

We will include RCTs and prospective or retrospective cohort studies of adults (≥18 years) with ND-CKD (eGFR <60) and iron deficiency (ferritin <100 μg/L; or ferritin >100 μg/L with TSAT <20%; or CHr <31 pg; or HRC >6%). Studies assessing IV iron with or without comparators will be included. Case reports and non-English studies will be excluded. Primary outcome: efficacy of IV iron. Secondary outcomes: cardiovascular events, infections, symptom burden, function, cognition, quality of life, and acceptability.

Results

Ten studies met inclusion criteria, with a combined population of 4026 participants. Data synthesis is ongoing and will be presented at the conference.

Conclusion

This review addresses a key evidence gap in managing iron deficiency in ND-CKD without anaemia. Findings may inform future research, guideline development, and clinical practice.

Included studies and participants
Study TitleNumber of Participants
McMahon 2010100
Ponikowski 2015459
Marques 2023120
van Veldhuisen 2017172
Kalra 20221137
von Haehling 202439
Al Sahow 2022738
Greenwood 202375
Bhandari 202154
Macdougall 20231132

Digital Object Identifier (DOI)